These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9412538)

  • 21. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure.
    Newton GE; Tong JH; Schofield AM; Baines AD; Floras JS; Parker JD
    J Am Coll Cardiol; 1996 Jul; 28(1):155-61. PubMed ID: 8752808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
    Meredith IT; Eisenhofer G; Lambert GW; Dewar EM; Jennings GL; Esler MD
    Circulation; 1993 Jul; 88(1):136-45. PubMed ID: 8391399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure.
    Floras JS
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):72A-84A. PubMed ID: 8376699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agreement among three different indices of sympathetic nervous system activity in essential hypertension.
    Esler M; Zweifler A; Randall O; Julius S; DeQuattro V
    Mayo Clin Proc; 1977 Jun; 52(6):379-82. PubMed ID: 865134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sympathetic neuronal regulation of the heart in aging and heart failure.
    Kaye D; Esler M
    Cardiovasc Res; 2005 May; 66(2):256-64. PubMed ID: 15820194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sympathetic nervous system in hypertension: back to the future?
    Esler M
    Curr Hypertens Rep; 2015 Feb; 17(2):11. PubMed ID: 25680900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normalization of total body and regional sympathetic hyperactivity in heart failure after heart transplantation.
    Rundqvist B; Elam M; Eisenhofer G; Friberg P
    J Heart Lung Transplant; 1996 May; 15(5):516-26. PubMed ID: 8771507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sympathetic system and hypertension.
    Esler M
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):99S-105S. PubMed ID: 10921528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance.
    Cohen-Solal A; Jacobson AF; Piña IL
    ESC Heart Fail; 2017 Nov; 4(4):499-506. PubMed ID: 29154422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension.
    Esler M
    Exp Physiol; 2011 Jul; 96(7):611-22. PubMed ID: 21551268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormalities in sympathoneuronal regulation are localized to failing myocardium in rabbit heart.
    Yoshikawa T; Handa S; Suzuki M; Nagami K
    J Am Coll Cardiol; 1994 Jul; 24(1):210-5. PubMed ID: 8006268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation.
    Lambert GW; Kaye DM; Vaz M; Cox HS; Turner AG; Jennings GL; Esler MD
    J Auton Nerv Syst; 1995 Nov; 55(3):169-78. PubMed ID: 8801267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans.
    Wallin BG; Esler M; Dorward P; Eisenhofer G; Ferrier C; Westerman R; Jennings G
    J Physiol; 1992; 453():45-58. PubMed ID: 1464839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.
    Zucker IH; Liu JL
    Heart Fail Rev; 2000 Mar; 5(1):27-43. PubMed ID: 16228914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder.
    Esler M; Alvarenga M; Lambert G; Kaye D; Hastings J; Jennings G; Morris M; Schwarz R; Richards J
    Ann N Y Acad Sci; 2004 Jun; 1018():505-14. PubMed ID: 15240408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac sympathetic denervation in Parkinson disease.
    Goldstein DS; Holmes C; Li ST; Bruce S; Metman LV; Cannon RO
    Ann Intern Med; 2000 Sep; 133(5):338-47. PubMed ID: 10979878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities.
    Floras JS
    Acta Physiol Scand; 2003 Mar; 177(3):391-8. PubMed ID: 12609011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy.
    Schlaich MP; Kaye DM; Lambert E; Sommerville M; Socratous F; Esler MD
    Circulation; 2003 Aug; 108(5):560-5. PubMed ID: 12847071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.
    Brunner-La Rocca HP; Esler MD; Jennings GL; Kaye DM
    Eur Heart J; 2001 Jul; 22(13):1136-43. PubMed ID: 11428854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart rate variability measurement correlates with cardiac norepinephrine spillover in congestive heart failure.
    Tygesen H; Rundqvist B; Waagstein F; Wennerblom B
    Am J Cardiol; 2001 Jun; 87(11):1308-11. PubMed ID: 11377364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.